H1B Report
Side-by-side comparison

TATA CONSULTANCY SERVICES LIMITED vs Unicon Pharma Inc

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
TATA CONSULTANCY SERVICES LIMITED
MDRank #3FEIN 98-0429806
Entity B
Unicon Pharma Inc
NJRank #FEIN 46-2554626

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricTATA CONSULTANCY SERVICES LIMITEDUnicon Pharma Inc
Total filings128,379679
Certified %99.22%75.55%
Denied %0.15%0.44%
Withdrawn %0.50%1.91%
Cert-withdrawn %0.13%22.09%
Rank#3
Active yearsFY2010–FY2026FY2014–FY2026
Worksite stateMDNJ

Outcomes — TATA CONSULTANCY SERVICES LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.2%, Cert-withdrawn 0.1%, Withdrawn 0.5%, Denied 0.1%
Outcome breakdown
OutcomeShare
Certified99.2%
Cert-withdrawn0.1%
Withdrawn0.5%
Denied0.1%
Certified99.2%
Cert-withdrawn0.1%
Withdrawn0.5%
Denied0.1%

Outcomes — Unicon Pharma Inc

DOL case-status mix.

Outcome breakdown: Certified 75.6%, Cert-withdrawn 22.1%, Withdrawn 1.9%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified75.6%
Cert-withdrawn22.1%
Withdrawn1.9%
Denied0.4%
Certified75.6%
Cert-withdrawn22.1%
Withdrawn1.9%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

TATA CONSULTANCY SERVICES LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,008
FY20115,386
FY20126,700
FY20138,724
FY201413,977
FY201516,514
FY201613,100
FY201713,511
FY201814,583
FY201911,853
FY202023
FY202115
FY202211
FY20232,459
FY20249,708
FY20257,886
FY20262,921
Unicon Pharma Inc
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20130
FY201419
FY201555
FY201682
FY201780
FY201872
FY2019107
FY202017
FY202116
FY20224
FY202338
FY202469
FY202572
FY202648

Top 5 occupations — TATA CONSULTANCY SERVICES LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.